Briefly, therapeutic interventions for asthma primarily target oxidative stress pathways through Nrf2 activators and mitochondrial antioxidants, while addressing inflammatory cascades via JAK-STAT inhibitors, NFκB modulators, and inflammasome inhibitors. This evidence concerns the gene NFE2L2 and asthma.